![Abhishek D. Garg: TIM3+VISTA+ macrophage subset that mediates resistance to anticancer immunotherapy and chemotherapy](https://oncodaily.com/pub/uploads/2023/11/download-92-e1716482504817-1280x960.jpg)
Photo taken from Abhishek D. Garg/LinkedIn
Jul 20, 2024, 11:34
Abhishek D. Garg: TIM3+VISTA+ macrophage subset that mediates resistance to anticancer immunotherapy and chemotherapy
Abhishek D. Garg,
“Thrilled to share our lab’s latest research on an unique, evolutionarily conserved, TIM3+VISTA+ macrophage subset that mediates widespread resistance to anticancer immunotherapy as well as chemotherapy!
Source: Abhishek D. Garg/LinkedIn
Abhishek D. Garg
anticancer immunotherapy
cancer
chemotherapy
Dirk Daelemans
Faculteit Geneeskunde KU Leuven Faculty of Medicine
FWO Research Foundation Flanders
Isaure Vanmeerbeek
Jannes Govaerts
Jenny Sprooten
Joren Verelst
KU Leuven
Leuven Cancer Institute
Louis Boon
Maarten Jacquemyn
Martyna Pociupany
Massimiliano Mazzone
OncoDaily
Oncology
Raquel Laureano
Research Foundation Flanders - FWO
Rosa Trotta
Sabine Tejpar
Samantha Pretto
Sarah Trusso Cafarello
Shikang Zhao
Stand Up Against Cancer
Stefan Naulaerts
Susan Schlenner
UZ Leuven